Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19-Reference-Cited by-同舟云学术

Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19

Published:2022-02-02 Issue:3 Volume:8 Page:E15-E17
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:

Author:

Ortega-Paz Luis¹,Galli Mattia²,Angiolillo Dominick J¹^ORCID

Affiliation:

1. Division of Cardiology, University of Florida College of Medicine , 5th floor, ACC Building, 655 West 8th Street, Jacksonville, FL 32209, USA

2. Catholic University of the Sacred Heart , Rome, Italy

Funder

Spanish Society of Cardiology

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/ehjcvp/advance-article-pdf/8/3/E15/43555202/pvac010.pdf

Reference8 articles.

1. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials;Ortega-Paz;Eur Heart J Cardiovasc Pharmacother

2. Coronavirus disease 2019-associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management;Ortega-Paz;J Am Heart Assoc,2021

3. Myocardial injury in COVID-19 patients: association with inflammation, coagulopathy and in-hospital prognosis;Arevalos;J Clin Med,2021

4. Efficacy and safety of therapeutic-dose heparin vs. standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial;Spyropoulos;JAMA Intern Med,2021

5. Therapeutic versus prophylactic bemiparin in hospitalized patients with nonsevere COVID-19 pneumonia (BEMICOP study): an open-label, multicenter, randomized, controlled trial;Marcos-Jubilar;Thromb Haemost,2022

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular prevention and risk factors;European Heart Journal - Cardiovascular Pharmacotherapy;2023-11-24

2. Cardiovascular preventive actions;European Heart Journal - Cardiovascular Pharmacotherapy;2023-09

3. The evaluation and management of coagulopathies in the intensive therapy units;European Heart Journal: Acute Cardiovascular Care;2023-05-12

4. The effect of anti-coagulation dosage on the outcome of hospitalized COVID-19 patients in Ethiopia: a multi-center retrospective cohort study;BMC Pulmonary Medicine;2023-03-13

5. The Conundrum of Anticoagulation for Hospitalized Patients with Covid-19;NEJM Evidence;2023-01-24